Neural Regeneration Research, 2017 · DOI: 10.4103/1673-5374.219052 · Published: November 1, 2017
Spinal cord injury (SCI) often results in motor and sensory function loss. Cell-based therapies are being explored in preclinical studies. The olfactory epithelium is a neurogenic tissue containing stem/progenitor cells that can be easily accessed for transplantation. Globose basal cells (GBCs) were isolated from rat olfactory epithelium and transplanted into rats with SCI to assess motor recovery and tissue regeneration. Globose basal cells (GBCs) were isolated from rat olfactory epithelium, characterized, and transplanted into injured rat spinal cords. The outcome of transplantation was assessed using behavioral and electrophysiological tests, as well as histological observation. This study found that GBCs express neural stem cell markers, form neurospheres, and differentiate into neuronal cells. GBC-transplanted rats showed improved hindlimb motor recovery and increased muscle electromyography amplitude. GFP-labeled GBCs survived and differentiated into neuron-like cells around the injury site, suggesting that GBCs could be an alternative cell source for autologous neurotransplantation after SCI.
GBCs from the olfactory epithelium can serve as an accessible alternative to NSCs for autologous transplantation.
Transplantation of GBCs can lead to significant hindlimb motor recovery in SCI rats.
GBCs exhibit therapeutic effects in experimental models of SCI, supporting their use in clinical applications.